Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction
暂无分享,去创建一个
S. Yamashita | M. Nishino | Hiroyasu Kato | J. Tanouchi | F. Sera | K. Nakamoto | H. Mizuno | S. Hikoso | Y. Sakata | Y. Makino | Y. Higuchi | M. Uematsu | Y. Koretsune | S. Hoshida | K. Iwakura | T. Onishi | T. Ohtani | T. Kitao | T. Kitamura | Y. Yasumura | Y. Matsumura | Y. Takeda | H. Kurakami | D. Nakatani | S. Suna | K. Harada | M. Asai | Takahisa Yamada | H. Kioka | S. Tamaki | M. Masuda | T. Takeda | S. Hasegawa | M. Izumi | M. Yano | M. Kumada | T. Mano | Tetsuya Watanabe | M. Fujita | K. Hirooka | Y. Ueda | Y. Nagai | Ryo Araki | Y. Shinoda | K. Nagai | D. Masuda | T. Dohi | Akito Nakagawa | T. Kojima | H. Kida | K. Nakatani | A. Sunaga | W. Shioyama | Y. Yasuga | Y. Sotomi | S. Nozaki | Takaharu Hayashi | Y. Nakagawa | N. Nishikawa | M. Nishio | Y. Takano | M. Ichikawa | Yo Arita | Y. Kijima | H. Fuji | Katsuki Okada | B. Oeun | Taiki Sato | T. Yoshimura | Y. Yasuoka | Takamaru Ishizu | H. Akagi | Hiroyoshi Yamamoto | Yasushi Okumoto | O. Nakagawa | H. Abe | Tomomi Yamada | Shunsuke Tetsuya Takaharu Masaharu Mitsutoshi Daisaku Yoshi Tamaki Watanabe Hayashi Masuda Asai Masu | M. Sairyo | E. Rin | A. Tani | H. Kanai | Takayuki Yamada | T. Yamada | Y. Arita | T. Hayashi | Yasunaka Makino | Shinichiro Suna | Takayuki Kojima | Osamu Nakagawa | Daisaku Masuda | Mayu Nishio | Toshihiro Takeda | Tomomi Yamada | Takayuki Yamada
[1] H. Nathoe,et al. Increased Visceral Adipose Tissue Is Associated With Increased Resting Heart Rate in Patients With Manifest Vascular Disease , 2012, Obesity.
[2] Y. Sakata,et al. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR). , 2020, European heart journal cardiovascular Imaging.
[3] Takashi Morita,et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.
[4] Paolo Marzullo,et al. From basic cardiac imaging to image fusion: Core competencies versus technological progress , 2013 .
[5] H. Iso,et al. Study protocol for the PURSUIT-HFpEF study: a Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction , 2020, BMJ Open.
[6] B. Massie,et al. Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection FractionClinical Perspective , 2011 .
[7] K. Nakajima,et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[8] E. Oda. New criteria for 'obesity disease' in Japan. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[9] A. Takeshita,et al. Characteristics and Outcomes of Hospitalized Patients With Heart Failure and Reduced vs Preserved Ejection Fraction , 2009 .
[10] W. Burchert,et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[11] T. Nakata,et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. , 2013, JACC. Cardiovascular imaging.
[12] M. Cerqueira,et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[13] G. Heller,et al. Relationship between quantitative cardiac neuronal imaging with 123I-meta-iodobenzylguanidine and hospitalization in patients with heart failure , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[15] H. Mizuno,et al. Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure. , 2015, International journal of cardiology.
[16] P. Filardi,et al. Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[17] B. Pitt,et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] Robert N. Doughty,et al. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.
[19] L. Brewster,et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.
[20] Kenichi Nakajima,et al. Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database , 2016, Annals of Nuclear Medicine.
[21] F. Katsukawa,et al. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis , 2003, Acta Diabetologica.
[22] T. Tsujimoto,et al. Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF. , 2017, Journal of the American College of Cardiology.
[23] S. Beske,et al. Subcutaneous obesity is not associated with sympathetic neural activation. , 2004, American journal of physiology. Heart and circulatory physiology.
[24] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[25] S. Giorgio,et al. Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation. , 2015, Quantitative imaging in medicine and surgery.
[26] K. Nakajima,et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations , 2014, Journal of Nuclear Cardiology.
[27] A. Takeshita,et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[28] Y. Takeishi,et al. Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction - A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[29] Adrian F Hernandez,et al. Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.